Drugs that affect blood coagulation, fibrinolysis and hemostasis

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

A literature review of drugs that affect blood coagulation, fibrinolysis and hemostasis published in the year 2021 was conducted and yielded 70 systemic reviews, meta-analyses, observational studies, and case reports relevant to warfarin and direct-acting anticoagulants, low-molecular-weight heparins, aminocaproic acid, tranexamic acid, idarucizumab, andexanet alfa, and tissue plasminogen activators.

Original languageEnglish
Title of host publicationA Worldwide Yearly Survey of New Data in Adverse Drug Reactions
EditorsSidhartha D. Ray
PublisherElsevier B.V.
Pages247-260
Number of pages14
ISBN (Print)9780323989091
DOIs
StatePublished - Jan 2022

Publication series

NameSide Effects of Drugs Annual
Volume44
ISSN (Print)0378-6080

Keywords

  • Anticoagulation
  • Anticoagulation reversal
  • Direct oral anticoagulant
  • Direct-acting anticoagulant
  • Prothrombotic
  • Thrombolytic
  • Thrombosis
  • Warfarin

Fingerprint

Dive into the research topics of 'Drugs that affect blood coagulation, fibrinolysis and hemostasis'. Together they form a unique fingerprint.

Cite this